These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11135429)

  • 1. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
    Huang H; Reed CP; Zhang JS; Shridhar V; Wang L; Smith DI
    Cancer Res; 1999 Jun; 59(12):2981-8. PubMed ID: 10383164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress.
    Louis M; Rosato RR; Brault L; Osbild S; Battaglia E; Yang XH; Grant S; Bagrel D
    Int J Oncol; 2004 Dec; 25(6):1701-11. PubMed ID: 15547708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
    Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
    Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
    Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells.
    Jung JW; Cho SD; Ahn NS; Yang SR; Park JS; Jo EH; Hwang JW; Aruoma OI; Lee YS; Kang KS
    Cancer Lett; 2006 Sep; 241(2):301-8. PubMed ID: 16337085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
    J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
    Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
    Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.
    Fournel M; Trachy-Bourget MC; Yan PT; Kalita A; Bonfils C; Beaulieu C; Frechette S; Leit S; Abou-Khalil E; Woo SH; Delorme D; MacLeod AR; Besterman JM; Li Z
    Cancer Res; 2002 Aug; 62(15):4325-30. PubMed ID: 12154036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.